Contact

Click here for a confidential contact or call:

1-212-350-2774

The Antitrust Week In Review

Posted  October 30, 2017

Here are some of the developments in antitrust news this past week that we found interesting and are following.

Bayer: more antitrust asset sales on the cards after BASF deal.  Bayer said it expected antitrust authorities to make the planned acquisition of Monsanto conditional on more asset sales after agreeing to sell seed and herbicide businesses for 5.9 billion euro ($7 billion) to BASF.  “By no means did the deal that was signed with BASF constitute the totality of antitrust divestitures … The agencies will render their verdict on what the necessary remedies are.  It’s probably a first step and somewhat more is to come,” Chief Executive Werner Baumann told an analyst call on Thursday after the release of third-quarter results.

Price-Fixing Inquiry Moves From BMW to Daimler and Volkswagen.  European Union investigators searched the offices of the German automakers Daimler and Volkswagen — the second such action in recent days as part of an inquiry into allegations of illegal collusion by the country’s car giants.  Regulators are looking into whether Germany’s three major vehicle manufacturers — BMW, Daimler and Volkswagen — worked together to fix the prices of various vehicle equipment, including design aspects that help control emissions.  The searches came as the companies face a backlash over their efforts to evade rules on diesel emissions.

CVS makes more than $66 billion bid for Aetna: sources.  U.S. pharmacy operator CVS Health Corp has made an offer to acquire No. 3 U.S. health insurer Aetna Inc for more than $200 per share, or over $66 billion, people familiar with the matter said on Thursday.  A deal would merge one of the nation’s largest pharmacy benefits managers and pharmacy operators with one of its oldest health insurers, whose far-reaching business ranges from employer healthcare to government plans nationwide.  A tie-up with Aetna could give CVS more leverage in its price negotiations with drug makers. But it would also subject it to more antitrust scrutiny.

Fiat Chrysler sues shippers over alleged price fixing.  Fiat Chrysler Automobiles NV has lodged a complaint with a U.S. regulator seeking “reparations” from a group of shipping companies from Asia, Europe and South America that admitted to fixing prices for shipping vehicles, according to documents made public on Monday.  The automaker wants the Federal Maritime Commission to order payments from Wallenius Wilhelmsen Logistics AS and its sister company EUKOR Car Carriers Inc, Nippon Yusen Kabushiki Kaisha, Mitsui O.S.K. Lines Ltd, Compania Sud Americana de Vapores VAP.SN, Hoegh Autoliners AS and affiliated companies.  The auto maker said it and its corporate predecessors have purchased “hundreds of millions of dollars” in delivery services and none of the firms have compensated it or other victims “of their illegal activities.”

Tagged in: Antitrust Enforcement, Antitrust Litigation, International Competition Issues,